Does NEMOLIZUMAB-ILTO Cause Dermatitis atopic? 117 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 117 reports of Dermatitis atopic have been filed in association with NEMOLIZUMAB-ILTO. This represents 2.8% of all adverse event reports for NEMOLIZUMAB-ILTO.
117
Reports of Dermatitis atopic with NEMOLIZUMAB-ILTO
2.8%
of all NEMOLIZUMAB-ILTO reports
0
Deaths
0
Hospitalizations
How Dangerous Is Dermatitis atopic From NEMOLIZUMAB-ILTO?
Of the 117 reports.
Is Dermatitis atopic Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NEMOLIZUMAB-ILTO. However, 117 reports have been filed with the FAERS database.
What Other Side Effects Does NEMOLIZUMAB-ILTO Cause?
Inappropriate schedule of product administration (826)
Product dose omission issue (792)
Device malfunction (761)
Incorrect dose administered (579)
Pruritus (416)
Rash (263)
Headache (181)
Drug ineffective (158)
Device leakage (153)
Device use issue (120)
What Other Drugs Cause Dermatitis atopic?
DUPILUMAB (33,670)
TRALOKINUMAB-LDRM (613)
UPADACITINIB (525)
RUXOLITINIB (211)
TACROLIMUS (200)
CRISABOROLE (134)
OMALIZUMAB (111)
ABROCITINIB (110)
PREDNISONE (105)
ADALIMUMAB (103)
Which NEMOLIZUMAB-ILTO Alternatives Have Lower Dermatitis atopic Risk?
NEMOLIZUMAB-ILTO vs NEOMYCIN
NEMOLIZUMAB-ILTO vs NEORAL
NEMOLIZUMAB-ILTO vs NEOSTIGMINE
NEMOLIZUMAB-ILTO vs NEOSTIGMINE METHYLSULFATE
NEMOLIZUMAB-ILTO vs NEPAFENAC